<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Applicability of Human Induced Pluripotent Stem Cell Models for Drug-Screening in Alzheimer’s Disease</title>
    <link rel="stylesheet" href="INO.css" />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
</head>

<body class="INO-page">
<header>
    <h1>Projects</h1>
</header>

<main>
    <section>
        <div class="project-intro-full">
            <h2>Applicability of Human Induced Pluripotent Stem Cell Models for Drug-Screening in Alzheimer’s Disease</h2>
            <p class="project-subtitle">Laurel Heights Secondary School &middot; 2021</p>
            <div class="project-intro">
                <div class="project-image">
                    <img src="images/stemcell.png" alt="INO eye movement visualization">
                </div>
                <div class="project-description">
                    <p>This research investigates how human induced pluripotent stem cells (hiPSCs) can be used to
                        create more accurate and ethical models for drug screening in Alzheimer’s disease. Unlike
                        traditional animal or generic cell models, hiPSCs can be derived from patient-specific cells
                        and engineered to express Alzheimer’s-relevant phenotypes, such as amyloid plaque buildup.</p>

                        <p>The project explored CRISPR-based mutation correction, phenotype acceleration using oxidative
                        stress, and histological staining for plaque detection. These innovations aim to enable faster
                        and more human-relevant preclinical testing of drugs like Colostrinin and anti-amyloid therapies.</p>
                </div>
            </div>
        </div>

        <div class="project-details">
            <h3>Key Factors</h3>
            <div class="project-blocks-container">

                <div class="project-block">
                    <h4><i class="fas fa-dna"></i> Patient-Specific hiPSC Derivation:</h4>
                    <ul>
                        <li>Reprogrammed somatic cells using OSKM transcription factors</li>
                        <li>Created disease-specific stem cells replicating Alzheimer’s pathology</li>
                        <li>Enabled personalized modeling for drug testing</li>
                    </ul>
                </div>

                <div class="project-block">
                    <h4><i class="fas fa-wrench"></i> Mutation Control via CRISPR-Cas9:</h4>
                    <ul>
                        <li>Used CRISPR-Cas9 for genome editing and mutation prevention</li>
                        <li>Applied both viral and non-viral delivery systems</li>
                        <li>Created nanocomplexes to reduce immunogenicity and improve targeting</li>
                    </ul>
                </div>

                <div class="project-block">
                    <h4><i class="fas fa-bolt"></i> Accelerated Phenotype Development:</h4>
                    <ul>
                        <li>Used oxidative stress to induce Alzheimer-like features faster</li>
                        <li>Reduced model development time from years to days/weeks</li>
                        <li>Enabled early-stage observation of drug impact on plaque buildup</li>
                    </ul>
                </div>

                <div class="project-block">
                    <h4><i class="fas fa-microscope"></i> Histological Staining for Analysis:</h4>
                    <ul>
                        <li>Used Congo Red and Thioflavin S to visualize amyloid plaques</li>
                        <li>Detected changes in plaque concentration before and after treatment</li>
                        <li>Enabled comparison with human and mouse trial results</li>
                    </ul>
                </div>

                <div class="project-block">
                    <h4><i class="fas fa-pills"></i> Relevance to Future Drug Testing:</h4>
                    <ul>
                        <li>Allows ethical and accurate testing of new drugs like Colostrinin</li>
                        <li>Improves understanding of drug effects on human-specific biology</li>
                        <li>Supports rapid pre-clinical validation of Alzheimer’s therapeutics</li>
                    </ul>
                </div>

            < </div>
            <a href="https://drive.google.com/file/d/1GUdYypTInTAvqiCLXSUWo3dya9K7xMs6/view?usp=sharing" class="button" target="_blank">View Full Report</a>
        </div>
    </section>
</main>


<footer>
    <p>&copy; Varsha Bandi</p>
</footer>

</body>
</html>
